{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:NL-KVK-34185938-ATMI-FY20", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "last-updated-datetime":"2024-05-06T14:54:29Z", "last_updated_datetime":"Mon May 06 14:54:29 UTC 2024", "last_updated_datetime_f":"2024-05-06T14:54:29Z", "lang":"en", "default_lang":"en", "default-currency":"EUR", "default_currency":"EUR", "humanitarian":false, "hierarchy":1, "iati-identifier":"NL-KVK-34185938-ATMI-FY20", "iati_identifier":"NL-KVK-34185938-ATMI-FY20", "reporting-org.type":"60", "reporting_org_type_code":"60", "reporting-org.ref":"NL-KVK-34185938", "reporting_org_ref":"NL-KVK-34185938", "reporting-org.narrative":["Access to Medicine Foundation"], "reporting_org_narrative":["Access to Medicine Foundation"], "reporting-org.narrative.lang":["en"], "title.narrative":["Access to Medicine Index FY20"], "title_narrative":["Access to Medicine Index FY20"], "title_narrative_text":["Access to Medicine Index FY20"], "title.narrative.lang":["en"], "title_narrative_lang":["en"], "description.type":["1"], "description_type":["1"], "description.narrative":["The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. This activity files includes the 2020 activities."], "description_narrative":["The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. This activity files includes the 2020 activities."], "description_narrative_text":["The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. This activity files includes the 2020 activities."], "description.narrative.lang":["en"], "description_narrative_lang":["en"], "participating-org.ref":["XM-DAC-7","GB-GOV-1","XM-DAC-DAC-1601"], "participating_org_ref":["XM-DAC-7","GB-GOV-1","XM-DAC-DAC-1601"], "participating-org.type":["10","10","60","70"], "participating_org_type":["10","10","60","70"], "participating-org.role":["1","1","1","1"], "participating_org_role":["1","1","1","1"], "participating-org.narrative":["Netherlands - Ministry of Foreign Affairs","UK - Foreign, Commonwealth and Development Office","Bill and Melinda Gates Foundation","AXA Investment Managers"], "participating_org_narrative":["Netherlands - Ministry of Foreign Affairs","UK - Foreign, Commonwealth and Development Office","Bill and Melinda Gates Foundation","AXA Investment Managers"], "participating_org_narrative_text":["Netherlands - Ministry of Foreign Affairs","UK - Foreign, Commonwealth and Development Office","Bill and Melinda Gates Foundation","AXA Investment Managers"], "participating-org.narrative.lang":["en","en","en"," "], "participating_org_narrative_lang":["en","en","en"," "], "participating-org.activity-id":["Not Available "], "activity-status.code":"2", "activity_status_code":"2", "activity-date.type":["2","3"], "activity_date_type":["2","3"], "activity-date.iso-date":["2020-01-01T00:00:00Z","2020-12-31T00:00:00Z"], "activity_date_iso_date":["2020-01-01T00:00:00Z","2020-12-31T00:00:00Z"], "recipient-country.code":["NL"], "recipient_country_code":["NL"], "recipient-country.percentage":[100.0], "recipient_country_percentage":[100.0], "recipient-country.narrative":["The Access to Medicine Index will measure pharmaceutical companies' efforts to improve access to medicine across 106 low- and middle-income countries. The Access to Medicine Index team is based in The Netherlands."], "recipient_country_narrative":["The Access to Medicine Index will measure pharmaceutical companies' efforts to improve access to medicine across 106 low- and middle-income countries. The Access to Medicine Index team is based in The Netherlands."], "recipient_country_narrative_text":["The Access to Medicine Index will measure pharmaceutical companies' efforts to improve access to medicine across 106 low- and middle-income countries. The Access to Medicine Index team is based in The Netherlands."], "recipient-country.narrative.lang":["en"], "recipient_country_narrative_lang":["en"], "sector.code":["12220"], "sector_code":["12220"], "sector.percentage":[100.0], "sector_percentage":[100.0], "sector.vocabulary":["1"], "sector_vocabulary":["1"], "budget.type":["1"], "budget_type":["1"], "budget.status":["2"], "budget_status":["2"], "budget.period-start.iso-date":["2020-01-01T00:00:00Z"], "budget_period_start_iso_date":["2020-01-01T00:00:00Z"], "budget.period-end.iso-date":["2020-12-31T00:00:00Z"], "budget_period_end_iso_date":["2020-12-31T00:00:00Z"], "budget.value":[1857383.0], "budget_value":[1857383.0], "budget.value.currency":["EUR"], "budget_value_currency":["EUR"], "budget.value.value-date":["2020-01-01T00:00:00Z"], "budget_value_date":["2020-01-01T00:00:00Z"], "transaction.transaction-type.code":["1","4","11","1","11","1","2","1","1","11","1","1","1","11"], "transaction_type":["1","4","11","1","11","1","2","1","1","11","1","1","1","11"], "transaction.transaction-date.iso-date":["2020-01-01T00:00:00Z","2020-12-31T00:00:00Z","2020-01-01T00:00:00Z","2020-03-26T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-06-22T00:00:00Z","2020-07-23T00:00:00Z","2020-05-28T00:00:00Z","2020-09-01T00:00:00Z","2020-01-01T00:00:00Z","2020-07-24T00:00:00Z","2020-01-01T00:00:00Z"], "transaction_date_iso_date":["2020-01-01T00:00:00Z","2020-12-31T00:00:00Z","2020-01-01T00:00:00Z","2020-03-26T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-06-22T00:00:00Z","2020-07-23T00:00:00Z","2020-05-28T00:00:00Z","2020-09-01T00:00:00Z","2020-01-01T00:00:00Z","2020-07-24T00:00:00Z","2020-01-01T00:00:00Z"], "transaction.value":[264524.0,425000.0,604276.0,250000.0,657815.0,107200.0,1857383.0,575000.0,250000.0,250000.0,250000.0,145943.0,500435.0,652200.0], "transaction_value":[264524.0,425000.0,604276.0,250000.0,657815.0,107200.0,1857383.0,575000.0,250000.0,250000.0,250000.0,145943.0,500435.0,652200.0], "transaction.description.narrative":["Deferred income from BMGF","Employee, depreciation, travel, financial, housing, consultants and supply expenses for the period 1 Jan 2020 - 30 Sept 2020.","Part of the grant agreement with UK-FCDO allocated to FY20","Transfer from FCDO","Part of the grant agreement with BMGF allocated to FY2020","Deferred income from MinBuza","ATMF commitment to spend on ATMI","2020 instalment Dutch MoFA","2020 instalment AXA-IM\n","Transfer from FCDO","Deferred income from FCDO","Transfer from BMGF","Part of the grant agreement with MinBuza allocated to 2020"], "transaction_description_narrative":["Deferred income from BMGF","Employee, depreciation, travel, financial, housing, consultants and supply expenses for the period 1 Jan 2020 - 30 Sept 2020.","Part of the grant agreement with UK-FCDO allocated to FY20","Transfer from FCDO","Part of the grant agreement with BMGF allocated to FY2020","Deferred income from MinBuza","ATMF commitment to spend on ATMI","2020 instalment Dutch MoFA","2020 instalment AXA-IM\n","Transfer from FCDO","Deferred income from FCDO","Transfer from BMGF","Part of the grant agreement with MinBuza allocated to 2020"], "transaction.description.narrative.lang":[" "," "," "," "," "," "," "," "," "," "," "," "," "], "transaction_description_lang":[" "," "," "," "," "," "," "," "," "," "," "," "," "], "transaction.value.currency":["USD","EUR","GBP","GBP","USD","EUR","EUR","EUR","EUR","EUR","GBP","GBP","USD","EUR"], "transaction_value_currency":["USD","EUR","GBP","GBP","USD","EUR","EUR","EUR","EUR","EUR","GBP","GBP","USD","EUR"], "transaction.value.value-date":["2020-01-01T00:00:00Z","2020-09-30T00:00:00Z","2020-01-01T00:00:00Z","2020-03-26T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-06-22T00:00:00Z","2020-07-23T00:00:00Z","2020-05-28T00:00:00Z","2020-09-01T00:00:00Z","2020-01-01T00:00:00Z","2020-07-24T00:00:00Z","2020-01-01T00:00:00Z"], "transaction_value_date":["2020-01-01T00:00:00Z","2020-09-30T00:00:00Z","2020-01-01T00:00:00Z","2020-03-26T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-06-22T00:00:00Z","2020-07-23T00:00:00Z","2020-05-28T00:00:00Z","2020-09-01T00:00:00Z","2020-01-01T00:00:00Z","2020-07-24T00:00:00Z","2020-01-01T00:00:00Z"], "transaction.provider-org.ref":["Minbuza","GB-GOV-1","GB-GOV-1","XM-DAC-DAC-1601","XM-DAC-7","AXA IM","GB-GOV-1","XM-DAC-DAC-1601","XM-DAC-7"], "transaction_provider_org_ref":["Minbuza","GB-GOV-1","GB-GOV-1","XM-DAC-DAC-1601","XM-DAC-7","AXA IM","GB-GOV-1","XM-DAC-DAC-1601","XM-DAC-7"], "transaction.provider-org.provider-activity-id":["XM-DAC-7-PPR-4000001257","XM-DAC-7-PPR-4000001257","XM-DAC-PPR-4000001257"], "transaction_provider_org_provider_activity_id":["XM-DAC-7-PPR-4000001257","XM-DAC-7-PPR-4000001257","XM-DAC-PPR-4000001257"], "transaction.provider-org.type":["10"], "transaction_provider_org_type":["10"], "transaction.provider-org.narrative":["Funding from FCDO"], "transaction_provider_org_narrative":["Funding from FCDO"], "transaction_provider_org_narrative_text":["Funding from FCDO"], "transaction.provider-org.narrative.lang":[" "], "transaction_provider_org_narrative_lang":[" "], "document-link.url":["https://accesstomedicinefoundation.org/resource/the-methodology-for-the-2021-access-to-medicine-index","https://accesstomedicinefoundation.org/news/progress-against-hiv-malaria-and-tb-is-under-threat-putting-children-at-risk-heres-what-is-needed","https://aidstream.s3.us-west-2.amazonaws.com/documents/AnnualReport_2020_AccesstoMedicineFoundation-20240506020543.pdf"], "document_link_url":["https://accesstomedicinefoundation.org/resource/the-methodology-for-the-2021-access-to-medicine-index","https://accesstomedicinefoundation.org/news/progress-against-hiv-malaria-and-tb-is-under-threat-putting-children-at-risk-heres-what-is-needed","https://aidstream.s3.us-west-2.amazonaws.com/documents/AnnualReport_2020_AccesstoMedicineFoundation-20240506020543.pdf"], "document-link.format":["application/pdf","application/pdf","application/pdf"], "document_link_format":["application/pdf","application/pdf","application/pdf"], "document-link.title.narrative":["Methodology for the 2021 Access to Medicine Index ","Ending the Burden of HIV, malaria and TB in Children","ATMF annual report 2020"], "document_link_title_narrative":["Methodology for the 2021 Access to Medicine Index ","Ending the Burden of HIV, malaria and TB in Children","ATMF annual report 2020"], "document_link_title_narrative_text":["Methodology for the 2021 Access to Medicine Index ","Ending the Burden of HIV, malaria and TB in Children","ATMF annual report 2020"], "document-link.title.narrative.lang":["en","en"," "], "document_link_title_narrative_lang":["en","en"," "], "document-link.category.code":["A02","A02","A08"], "document_link_category_code":["A02","A02","A08"], "document-link.language.code":["en","en","en"], "document_link_language_code":["en","en","en"], "document-link.document-date.iso-date":["2020-03-26T00:00:00Z","2020-06-09T00:00:00Z","2020-12-31T00:00:00Z"], "document_link_document_date_iso_date":["2020-03-26T00:00:00Z","2020-06-09T00:00:00Z","2020-12-31T00:00:00Z"], "result.type":["1","1","1"], "result_type":["1","1","1"], "result.title.narrative":["Writing and publication of refreshed Access to Medicine Index Methodology Report","Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women","ATMF Annual Report 2020"], "result_title_narrative":["Writing and publication of refreshed Access to Medicine Index Methodology Report","Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women","ATMF Annual Report 2020"], "result_title_narrative_text":["Writing and publication of refreshed Access to Medicine Index Methodology Report","Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women","ATMF Annual Report 2020"], "result.title.narrative.lang":["en","en","en"], "result_title_narrative_lang":["en","en","en"], "result.document-link.url":["https://accesstomedicinefoundation.org/publications/the-methodology-for-the-2020-access-to-medicine-index","https://accesstomedicinefoundation.org/media/uploads/downloads/5ee1fd19b7187_ATMF_Ending_the_Big3_on%20Children-Full_09June20.pdf","https://aidstream.s3.us-west-2.amazonaws.com/documents/AnnualReport_2020_AccesstoMedicineFoundation-20240506020514.pdf"], "result_document_link_url":["https://accesstomedicinefoundation.org/publications/the-methodology-for-the-2020-access-to-medicine-index","https://accesstomedicinefoundation.org/media/uploads/downloads/5ee1fd19b7187_ATMF_Ending_the_Big3_on%20Children-Full_09June20.pdf","https://aidstream.s3.us-west-2.amazonaws.com/documents/AnnualReport_2020_AccesstoMedicineFoundation-20240506020514.pdf"], "result.document-link.format":["application/pdf","application/pdf","application/pdf"], "result_document_link_format":["application/pdf","application/pdf","application/pdf"], "result.document-link.title.narrative":["Methodology for the 2020 Access to Medicine Index","Ending the burden of HIV, malaria and TB in children","ATMF Annual Report 2020"], "result_document_link_title_narrative":["Methodology for the 2020 Access to Medicine Index","Ending the burden of HIV, malaria and TB in children","ATMF Annual Report 2020"], "result_document_link_title_narrative_text":["Methodology for the 2020 Access to Medicine Index","Ending the burden of HIV, malaria and TB in children","ATMF Annual Report 2020"], "result.document-link.title.narrative.lang":["en","en","en"], "result_document_link_title_narrative_lang":["en","en","en"], "result.document-link.category.code":["A08","A08","A08"], "result_document_link_category_code":["A08","A08","A08"], "result.document-link.document-date.iso-date":["2020-03-26T00:00:00Z"], "result_document_link_document_date_iso_date":["2020-03-26T00:00:00Z"], "result.indicator.measure":["1","1","1"], "result_indicator_measure":["1","1","1"], "result.indicator.title.narrative":["Writing and publication of refreshed Access to Medicine Index Methodology Report","Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women","ATMF Annual Report 2020"], "result_indicator_title_narrative":["Writing and publication of refreshed Access to Medicine Index Methodology Report","Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women","ATMF Annual Report 2020"], "result_indicator_title_narrative_text":["Writing and publication of refreshed Access to Medicine Index Methodology Report","Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women","ATMF Annual Report 2020"], "result.indicator.title.narrative.lang":["en","en","en"], "result_indicator_title_narrative_lang":["en","en","en"], "result.indicator.period.period-start.iso-date":["2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-12-31T00:00:00Z"], "result_indicator_period_period_start_iso_date":["2020-01-01T00:00:00Z","2020-01-01T00:00:00Z","2020-12-31T00:00:00Z"], "result.indicator.period.period-end.iso-date":["2020-03-31T00:00:00Z","2020-09-30T00:00:00Z","2020-12-31T00:00:00Z"], "result_indicator_period_period_end_iso_date":["2020-03-31T00:00:00Z","2020-09-30T00:00:00Z","2020-12-31T00:00:00Z"], "result.indicator.period.target.value":["1","1"], "result_indicator_period_target_value":["1","1"], "result.indicator.period.actual.value":["1","1"], "result_indicator_period_actual_value":["1","1"], "result.description.narrative":["ATMF Annual Report 2020"], "result_description_narrative":["ATMF Annual Report 2020"], "result_description_narrative_text":["ATMF Annual Report 2020"], "result.description.narrative.lang":["en"], "result_description_narrative_lang":["en"], "result.indicator.description.narrative":["ATMF Annual Report 2020"], "result_indicator_description_narrative":["ATMF Annual Report 2020"], "result_indicator_description_narrative_text":["ATMF Annual Report 2020"], "result.indicator.description.narrative.lang":["en"], "result_indicator_description_narrative_lang":["en"], "reporting-org.type.name":"Foundation", "reporting_org_type_name":"Foundation", "recipient-country.name":["Netherlands (Kingdom of the)"], "recipient_country_name":["Netherlands (Kingdom of the)"], "budget.type.name":["Original"], "budget.status.name":["Committed"], "title.narrative.first":"Access to Medicine Index FY20", "title_narrative_first":"Access to Medicine Index FY20", "activity-date.start-actual":"2020-01-01T00:00:00Z", "activity_date_start_actual":"Wed Jan 01 00:00:00 UTC 2020", "activity_date_start_actual_f":"2020-01-01T00:00:00Z", "activity-date.common.start":"2020-01-01T00:00:00Z", "activity_date_start_common":"Wed Jan 01 00:00:00 UTC 2020", "activity_date_start_common_f":"2020-01-01T00:00:00Z", "activity-date.end-planned":"2020-12-31T00:00:00Z", "activity_date_end_planned":"Thu Dec 31 00:00:00 UTC 2020", "activity_date_end_planned_f":"2020-12-31T00:00:00Z", "activity-date.common.end":"2020-12-31T00:00:00Z", "activity_date_end_common":"Thu Dec 31 00:00:00 UTC 2020", "activity_date_end_common_f":"2020-12-31T00:00:00Z", "activity-status.text":"Implementation", "activity_status_text":"Implementation", "budget.value-usd":[2061877.1847136002], "budget_value_usd":[2061877.1847136002], "budget.value-usd.sum":2061877.1847136002, "budget_value_usd_sum":2061877.1847136002, "budget.value-usd.conversion-rate":[0.9008213553020108], "budget_usd_conversion_rate":[0.9008213553020108], "budget.value-usd.conversion-currency":["EUR"], "budget.value-gbp":[1577306.1168362796], "budget_value_gbp":[1577306.1168362796], "budget.value-gbp.sum":1577306.1168362796, "budget_value_gbp_sum":1577306.1168362796, "budget.value-gbp.conversion-rate":[1.177566599263237], "budget_gbp_conversion_rate":[1.177566599263237], "budget.value-gbp.conversion-currency":["EUR"], "transaction.value-usd.sum":7649345.73804734, "transaction_value_usd_sum":7649345.73804734, "transaction.value-usd.conversion-rate":[1.0,0.848316566688074,0.7649854843586968,0.808048366129009,1.0,0.9008213553020108,0.9008213553020108,0.8885381414006841,0.8710749326807228,0.9171320902532515,0.7718705629336932,0.7649854843586968,1.0,0.9008213553020108], "transaction_usd_conversion_rate":[1.0,0.848316566688074,0.7649854843586968,0.808048366129009,1.0,0.9008213553020108,0.9008213553020108,0.8885381414006841,0.8710749326807228,0.9171320902532515,0.7718705629336932,0.7649854843586968,1.0,0.9008213553020108], "transaction.value-usd.conversion-currency":["USD"], "transaction.value-gbp.sum":5923958.963947504, "transaction_value_gbp_sum":5923958.963947504, "transaction.value-gbp.conversion-rate":[1.3072143464765489,1.0990399264143824,1.0,1.0,1.3072143464765489,1.177566599263237,1.177566599263237,1.1126040710077885,1.1046980843425687,1.128395657188461,1.0,1.0,1.2682009812208388,1.177566599263237], "transaction_gbp_conversion_rate":[1.3072143464765489,1.0990399264143824,1.0,1.0,1.3072143464765489,1.177566599263237,1.177566599263237,1.1126040710077885,1.1046980843425687,1.128395657188461,1.0,1.0,1.2682009812208388,1.177566599263237], "transaction.value-gbp.conversion-currency":["USD"], "dataset.id":"35a8b0af-941d-48f3-a4b2-5246927f493f", "dataset_iati_id":"35a8b0af-941d-48f3-a4b2-5246927f493f", "dataset.name":"atmf-activity", "dataset_name":"atmf-activity", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"56633437f7d340227dbc3e931958ec6233b91b34", "dataset.resources.url":"https://aidstream.s3.us-west-2.amazonaws.com/xml/atmf-activities.xml", "activity-date.quarter":[1,4], "budget.period-start.quarter":[1], "budget.period-end.quarter":[4], "transaction.transaction-date.quarter":[1,4,1,1,1,1,1,2,3,2,3,1,3,1], "document-link.document-date.quarter":[1,2,4], "result.document-link.document-date.quarter":[1], "result.indicator.period.period-start.quarter":[1,1,4], "result.indicator.period.period-end.quarter":[1,3,4], "document-link.category-codes-combined":["A02","A02","A08"], "transaction.value-usd":[264524.0,500992.2199907626,789918.256431463,309387.42095059966,657815.0,119002.50739954978,2061877.1847136002,647130.3517636,287001.71549034014,272588.86986602604,323888.50152519165,190778.78336782698,500435.0,724005.9265483803], "transaction_value_usd":[264524.0,500992.2199907626,789918.256431463,309387.42095059966,657815.0,119002.50739954978,2061877.1847136002,647130.3517636,287001.71549034014,272588.86986602604,323888.50152519165,190778.78336782698,500435.0,724005.9265483803], "transaction.value-usd-type":[1,4,11,1,11,1,2,1,1,11,1,1,1,11], "transaction.value-gbp":[202357.0202644999,386701.14686967054,604276.0,250000.0,503218.9263934161,91035.19076294398,1577306.1168362796,516805.5869858262,226306.1768128083,221553.49358832726,250000.0,145943.0,394602.28103455197,553854.0243991797], "transaction_value_gbp":[202357.0202644999,386701.14686967054,604276.0,250000.0,503218.9263934161,91035.19076294398,1577306.1168362796,516805.5869858262,226306.1768128083,221553.49358832726,250000.0,145943.0,394602.28103455197,553854.0243991797], "transaction.value-gbp-type":[1,4,11,1,11,1,2,1,1,11,1,1,1,11], "activity-aggregation.budget.value":1857383.0, "activity_aggregation_budget_value":1857383.0, "activity-aggregation.budget.value-usd":2061877.1847136002, "activity_aggregation_budget_value_usd":2061877.1847136002, "activity-aggregation.budget.value-gbp":1577306.1168362796, "activity_aggregation_budget_value_gbp":1577306.1168362796, "activity-aggregation.budget.currency":"EUR", "activity_aggregation_budget_currency":"EUR", "activity-aggregation.incoming-funds.value":2343102.0, "activity_aggregation_incoming_funds_value":2343102.0, "activity-aggregation.incoming-funds.value-usd":2642148.2804971086, "activity_aggregation_incoming_funds_value_usd":2642148.2804971086, "activity-aggregation.incoming-funds.value-gbp":2077049.2558606304, "activity_aggregation_incoming_funds_value_gbp":2077049.2558606304, "activity-aggregation.outgoing-commitment.value":1857383.0, "activity_aggregation_commitment_value":1857383.0, "activity-aggregation.outgoing-commitment.value-usd":2061877.1847136002, "activity_aggregation_commitment_value_usd":2061877.1847136002, "activity-aggregation.outgoing-commitment.value-gbp":1577306.1168362796, "activity_aggregation_commitment_value_gbp":1577306.1168362796, "activity-aggregation.expenditure.value":425000.0, "activity_aggregation_expenditure_value":425000.0, "activity-aggregation.expenditure.value-usd":500992.2199907626, "activity_aggregation_expenditure_value_usd":500992.2199907626, "activity-aggregation.expenditure.value-gbp":386701.14686967054, "activity_aggregation_expenditure_value_gbp":386701.14686967054, "activity-aggregation.incoming-commitment.value":2164291.0, "activity_aggregation_incoming_commitment_value":2164291.0, "activity-aggregation.incoming-commitment.value-usd":2444328.0528458697, "activity_aggregation_incoming_commitment_value_usd":2444328.0528458697, "activity-aggregation.incoming-commitment.value-gbp":1882902.4443809232, "activity_aggregation_incoming_commitment_value_gbp":1882902.4443809232, "json.reporting-org":"{\"type\": 60, \"ref\": \"NL-KVK-34185938\", \"narrative\": \"Access to Medicine Foundation\", \"narrative.lang\": \"en\"}", "json.title":"{\"narrative\": \"Access to Medicine Index FY20\", \"narrative.lang\": \"en\"}", "json.description":["{\"type\": 1, \"narrative\": \"The Access to Medicine Index analyses 20 of the world\\u2019s largest research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. This activity files includes the 2020 activities.\", \"narrative.lang\": \"en\"}"], "json.participating-org":["{\"ref\": \"XM-DAC-7\", \"type\": 10, \"role\": 1, \"narrative\": \"Netherlands - Ministry of Foreign Affairs\", \"narrative.lang\": \"en\"}","{\"ref\": \"GB-GOV-1\", \"type\": 10, \"role\": 1, \"narrative\": \"UK - Foreign, Commonwealth and Development Office\", \"narrative.lang\": \"en\"}","{\"ref\": \"XM-DAC-DAC-1601\", \"type\": 60, \"role\": 1, \"narrative\": \"Bill and Melinda Gates Foundation\", \"narrative.lang\": \"en\"}","{\"type\": 70, \"role\": 1, \"activity-id\": \"Not Available \", \"narrative\": \"AXA Investment Managers\", \"narrative.lang\": \" \"}"], "json.activity-date":["{\"type\": 2, \"iso-date\": \"2020-01-01\"}","{\"type\": 3, \"iso-date\": \"2020-12-31\"}"], "json.recipient-country":["{\"code\": \"NL\", \"percentage\": 100, \"narrative\": \"The Access to Medicine Index will measure pharmaceutical companies' efforts to improve access to medicine across 106 low- and middle-income countries. The Access to Medicine Index team is based in The Netherlands.\", \"narrative.lang\": \"en\"}"], "json.sector":["{\"code\": 12220, \"percentage\": 100, \"vocabulary\": 1}"], "json.budget":["{\"type\": 1, \"status\": 2, \"period-start\": [{\"iso-date\": \"2020-01-01\"}], \"period-end\": [{\"iso-date\": \"2020-12-31\"}], \"value\": 1857383, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-01-01\"}"], "json.transaction":["{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 264524, \"description\": {\"narrative\": \"Deferred income from BMGF\", \"narrative.lang\": \" \"}, \"value.currency\": \"USD\", \"value.value-date\": \"2020-01-01\"}","{\"transaction-type\": {\"code\": 4}, \"transaction-date\": {\"iso-date\": \"2020-12-31\"}, \"value\": 425000, \"description\": {\"narrative\": \"Employee, depreciation, travel, financial, housing, consultants and supply expenses for the period 1 Jan 2020 - 30 Sept 2020.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"Minbuza\", \"provider-activity-id\": \"XM-DAC-7-PPR-4000001257\", \"type\": 10}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-09-30\"}","{\"transaction-type\": {\"code\": 11}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 604276, \"description\": {\"narrative\": \"Part of the grant agreement with UK-FCDO allocated to FY20\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-GOV-1\"}, \"value.currency\": \"GBP\", \"value.value-date\": \"2020-01-01\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-03-26\"}, \"value\": 250000, \"description\": {\"narrative\": \"Transfer from FCDO\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-GOV-1\"}, \"value.currency\": \"GBP\", \"value.value-date\": \"2020-03-26\"}","{\"transaction-type\": {\"code\": 11}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 657815, \"description\": {\"narrative\": \"Part of the grant agreement with BMGF allocated to FY2020\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"XM-DAC-DAC-1601\"}, \"value.currency\": \"USD\", \"value.value-date\": \"2020-01-01\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 107200, \"description\": {\"narrative\": \"Deferred income from MinBuza\", \"narrative.lang\": \" \"}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-01-01\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 1857383, \"description\": {\"narrative\": \"ATMF commitment to spend on ATMI\", \"narrative.lang\": \" \"}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-01-01\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-06-22\"}, \"value\": 575000, \"description\": {\"narrative\": \"2020 instalment Dutch MoFA\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"XM-DAC-7\", \"provider-activity-id\": \"XM-DAC-7-PPR-4000001257\"}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-06-22\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-07-23\"}, \"value\": 250000, \"description\": {\"narrative\": \"2020 instalment AXA-IM\\n\", \"narrative.lang\": \" \"}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-07-23\"}","{\"transaction-type\": {\"code\": 11}, \"transaction-date\": {\"iso-date\": \"2020-05-28\"}, \"value\": 250000, \"provider-org\": {\"ref\": \"AXA IM\"}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-05-28\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-09-01\"}, \"value\": 250000, \"description\": {\"narrative\": \"Transfer from FCDO\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-GOV-1\", \"narrative\": \"Funding from FCDO\", \"narrative.lang\": \" \"}, \"value.currency\": \"GBP\", \"value.value-date\": \"2020-09-01\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 145943, \"description\": {\"narrative\": \"Deferred income from FCDO\", \"narrative.lang\": \" \"}, \"value.currency\": \"GBP\", \"value.value-date\": \"2020-01-01\"}","{\"transaction-type\": {\"code\": 1}, \"transaction-date\": {\"iso-date\": \"2020-07-24\"}, \"value\": 500435, \"description\": {\"narrative\": \"Transfer from BMGF\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"XM-DAC-DAC-1601\"}, \"value.currency\": \"USD\", \"value.value-date\": \"2020-07-24\"}","{\"transaction-type\": {\"code\": 11}, \"transaction-date\": {\"iso-date\": \"2020-01-01\"}, \"value\": 652200, \"description\": {\"narrative\": \"Part of the grant agreement with MinBuza allocated to 2020\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"XM-DAC-7\", \"provider-activity-id\": \"XM-DAC-PPR-4000001257\"}, \"value.currency\": \"EUR\", \"value.value-date\": \"2020-01-01\"}"], "json.document-link":["{\"url\": \"https://accesstomedicinefoundation.org/resource/the-methodology-for-the-2021-access-to-medicine-index\", \"format\": \"application/pdf\", \"title\": {\"narrative\": \"Methodology for the 2021 Access to Medicine Index \", \"narrative.lang\": \"en\"}, \"category\": [{\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2020-03-26\"}]}","{\"url\": \"https://accesstomedicinefoundation.org/news/progress-against-hiv-malaria-and-tb-is-under-threat-putting-children-at-risk-heres-what-is-needed\", \"format\": \"application/pdf\", \"title\": {\"narrative\": \"Ending the Burden of HIV, malaria and TB in Children\", \"narrative.lang\": \"en\"}, \"category\": [{\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2020-06-09\"}]}","{\"url\": \"https://aidstream.s3.us-west-2.amazonaws.com/documents/AnnualReport_2020_AccesstoMedicineFoundation-20240506020543.pdf\", \"format\": \"application/pdf\", \"title\": {\"narrative\": \"ATMF annual report 2020\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2020-12-31\"}]}"], "json.result":["{\"type\": 1, \"title\": {\"narrative\": \"Writing and publication of refreshed Access to Medicine Index Methodology Report\", \"narrative.lang\": \"en\"}, \"document-link\": [{\"url\": \"https://accesstomedicinefoundation.org/publications/the-methodology-for-the-2020-access-to-medicine-index\", \"format\": \"application/pdf\", \"title\": {\"narrative\": \"Methodology for the 2020 Access to Medicine Index\", \"narrative.lang\": \"en\"}, \"category\": {\"code\": \"A08\"}, \"document-date\": [{\"iso-date\": \"2020-03-26\"}]}], \"indicator\": [{\"measure\": 1, \"title\": {\"narrative\": \"Writing and publication of refreshed Access to Medicine Index Methodology Report\", \"narrative.lang\": \"en\"}, \"period\": [{\"period-start\": [{\"iso-date\": \"2020-01-01\"}], \"period-end\": [{\"iso-date\": \"2020-03-31\"}], \"target\": [{\"value\": 1}], \"actual\": [{\"value\": 1}]}]}]}","{\"type\": 1, \"title\": {\"narrative\": \"Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women\", \"narrative.lang\": \"en\"}, \"document-link\": [{\"url\": \"https://accesstomedicinefoundation.org/media/uploads/downloads/5ee1fd19b7187_ATMF_Ending_the_Big3_on%20Children-Full_09June20.pdf\", \"format\": \"application/pdf\", \"title\": {\"narrative\": \"Ending the burden of HIV, malaria and TB in children\", \"narrative.lang\": \"en\"}, \"category\": {\"code\": \"A08\"}}], \"indicator\": [{\"measure\": 1, \"title\": {\"narrative\": \"Research, writing and publication of a white paper on paediatric resistance pertaining to HIV, malaria and TB and the impact it has on mothers, primary caregivers and pregnant women\", \"narrative.lang\": \"en\"}, \"period\": [{\"period-start\": [{\"iso-date\": \"2020-01-01\"}], \"period-end\": [{\"iso-date\": \"2020-09-30\"}], \"target\": [{\"value\": 1}], \"actual\": [{\"value\": 1}]}]}]}","{\"type\": 1, \"title\": {\"narrative\": \"ATMF Annual Report 2020\", \"narrative.lang\": \"en\"}, \"description\": {\"narrative\": \"ATMF Annual Report 2020\", \"narrative.lang\": \"en\"}, \"document-link\": [{\"url\": \"https://aidstream.s3.us-west-2.amazonaws.com/documents/AnnualReport_2020_AccesstoMedicineFoundation-20240506020514.pdf\", \"format\": \"application/pdf\", \"title\": {\"narrative\": \"ATMF Annual Report 2020\", \"narrative.lang\": \"en\"}, \"category\": {\"code\": \"A08\"}}], \"indicator\": [{\"measure\": 1, \"title\": {\"narrative\": \"ATMF Annual Report 2020\", \"narrative.lang\": \"en\"}, \"description\": {\"narrative\": \"ATMF Annual Report 2020\", \"narrative.lang\": \"en\"}, \"period\": [{\"period-start\": [{\"iso-date\": \"2020-12-31\"}], \"period-end\": [{\"iso-date\": \"2020-12-31\"}]}]}]}"], "id":"737a097b-9990-48b7-a8c8-8d4a7b852328", "_version_":1866660454446661632 }] } }